Medicines to prevent heart damage from radiation
Part of Brain & nervous system, Cancer, Digestive system, Heart & circulation, Lungs & breathing, Skin clinical trials.
This trial tests whether common heart medicines (statins or ACE-inhibitors) can protect the heart during cancer radiation therapy. It is for adults who are about to start chest radiation and have not taken these drugs before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are willing to give blood samples for the study
- You are not already taking a statin or ACE-inhibitor
- You do not have low blood pressure (hypotension)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how radiation therapy affects the heart in people being treated for lung, esophageal, or breast cancer. By watching the heart during and after treatment, researchers hope to find ways to lower heart side effects.
This study looks at how information about the heart may affect treatment decisions for people receiving radiation therapy for breast cancer. It aims to help reduce heart-related side effects from treatment.
This study tests a way to adjust radiation doses for people getting chest radiation, using a wearable device to watch for heart rhythm problems. It aims to reduce the chance of irregular heartbeats after treatment.
This study monitors how the heart and lungs respond to radiation therapy combined with immunotherapy for locally advanced lung cancer. It aims to learn how well patients tolerate treatment and to detect early signs of side effects.
This study looks at how chest radiation affects heart function and the immune system, and whether it is safe in people with lung, esophageal, breast, or thymus cancer who have not had chest radiation before.
This study looks at how chest radiation treatment affects the heart and lungs in people with certain lung or esophagus cancers. It may help doctors better predict and prevent these side effects during curative (aimed at cure) radiotherapy.
Hear when a new Chest Wall Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.